Research Council Announcements: Grants

Grants announcements from the MassGeneral Hospital for Children Research Council.


MGH ECOR Formulaic Bridge Funding


What is it? Formulaic Bridge Funding Support is offered to assist MGH Principal Investigators during a lapse or delay in their funding from NIH. To be eligible for Formulaic Bridge Funding, applicants must have applied as a PI for an R01 or R21 grant to support an independent, long-term research program.

The Formulaic Bridge process is open to:

1. Investigators whose grants received a score < or = 20th percentile and have received written communication from the NIH that the grant will not be funded.

2. Investigators whose grants received a fundable score (< or = 20th percentile) but are 3 months past the nominal start date of the the grant.


When is the deadline? 7th day of each month.


How do I learn more and apply? Click here to read more and apply online.
Visit the ECOR website and specifically the Formulaic Bridge Funding Support under the Awards and Grants tab of the site.




The Executive Committee on Research (ECOR) is accepting applications for the December 1st, 2014 deadline for the Deliberative Interim Support Funding & Sequestration Relief Funding. December is the third of three standing deadlines for these awards in 2014. The next deadline will be April 1, 2015.


What are they?

Deliberative Interim Support Funding 
This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense). Investigators must have applied for independent, long-term support (R01, R21, U01 and P01). The Deliberative Interim Support process is open to:

  • Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
  • Investigators whose grants received scores >20th percentile.
  • Investigators who were awarded Formulaic Bridge Funding (grants with scores < or = 20th percentile), and are now requesting additional financial support (in excess of $75,000 for RO1s, and $37,500 for R21s).
  • A PI who has already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application must apply through the Deliberative Interim Support process for their A0 or A1 resubmission regardless of the score they received on their resubmitted grant.

Sequestration Relief Funding
This is open to Investigators that have experienced a funding shortfall as a result of sequestration and do not qualify for either Formulaic Bridge Funding or Deliberative Interim Support.

For eligible applicants:

  • The total funded amount, if awarded, will be sourced 50:50 with the Department. For example, if a PI applies for $100,000, then $50,000 will be sourced from ECOR funds and $50,000 will be sourced from Departmental funds.
  • All applications for additional funds must include the Letter of Support & Cost Sharing Authorization Form for ECOR Funding.

When is the deadline?
Monday, December 1, 2014 - 5:00 PM

How do I learn more and apply?Deliberative Interim Support Funding - Click here

Sequestration Relief Funding - Click here



Bill & Melinda Gates Foundation -- Grand Challenges Explorations


Bill & Melinda Gates Foundation is now inviting applications to Grand Challenges Explorations, which has awarded over 1070 grants in over 58 countries to date.

Grand Challenges Explorations seeks innovative global health and development solutions. Applicants can be at any experience level; in any discipline; and from any organization, including universities, government laboratories, research institutions, non-profit organizations as well as for-profit companies.


Two-page proposals for the following will be accepted until January 13, 2015:

Full descriptions of the new topics and application instructions are available at:




Fighting Ebola: A Grand Challenge for Development


In response to the ongoing Ebola epidemic, the U.S. Agency for International Development (USAID) has launched Fighting Ebola: A Grand Challenge for Development to develop practical and cost-effective innovations to improve infection treatment and control that can be rapidly deployed. Submissions received by November 7, 2014, will be part of the first round of review, and submissions received by December 1, 2014, will be part of the second round of review. Expressions of interest received after December 1, 2014, will be reviewed in subsequent rounds.



Gilead Sciences Research Scholars Program in HIV


This Program supports innovative scientific research that will advance knowledge in the field of HIV.  The awards provide financial support to 3 junior faculty researchers for a 2-year period.  Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years.  


For a complete overview of the program, please go to:  


The deadline for online application submission is 12am on Friday, December 12, 2014



Damon Runyon Cancer Research Foundation Clinical Investigator Award


Internal Application Deadline: November 25, 2014 by 5:00pm

Funding Amount: $450,000 over 3 years plus debt repayment program


The Clinical Investigator Award program supports early career physician-scientists conducting patient-oriented research. The goal of this innovative program is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments.

Clinical Research is defined as:
1.Patient-oriented research: research conducted with human subjects
2.Epidemiologic and behavioral studies
3.Outcomes research and health services research
Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. This award is designed to support physicians who adhere to "The Handshake Rule," meaning that he/she will conduct research studies that directly involve patients.


Eligibility Criteria:

1.Applicants must be an instructor or assistant professor.
2.Applicants must have received an MD or MD/PhD degree(s), completed his/her subspecialty training and be board-eligible.
3.Applicants must be within the first four years of assistant professor appointment (cut-off July 1, 2011).
4.Applicants must apply in conjunction with a mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide critical guidance during the period of the award.
5.Must commit 80% time to research.
6.Applicants may not concurrently hold another physician-scientist career development award from a private source. See foundation website for examples. Candidates holding or awarded R01s at the time of application are not eligible to apply.
7.Must be a U.S. citizen or permanent resident


Applicants are encouraged to review the Foundation website as well as the list of most recently awarded grants.


To apply please visit the link below:


HMS Foundation Funds application



BADERC Pilot and Feasibility Research Grant Award Applications


The Boston Area Diabetes Endocrinology Research Center is now accepting pilot and feasibility research grant award applications for studies of diabetes mellitus and its complications. The Boston Area Diabetes Endocrinology Research Center is funded by the National Institute of Diabetes and Digestive Diseases (NIDDK) to support research in Diabetes and its complications.  Research grants up to $30,000 will be awarded for meritorious proposals from candidates whose eligibility is defined by one or more of the following three criteria:


1.         Junior faculty without past or current NIH support to conduct diabetes research. Not eligible if you have any support that is mandatory 100% effort where you cannot accept any federal funding.


2.         Established non-diabetes researchers who have an innovative idea relevant to diabetes.


3.         Established diabetes investigators who have an innovative idea/approach relevant to diabetes that represents a distinct departure from their established line of investigation.


4.         Co-PIs are not allowed, and if you are not accepting salary and or less than 5%, please mention if there is cost sharing.


It is anticipated that up to four meritorious applications will be funded.


Letters of intent, biosketch, other support and abstract due November 21. If proposal accepted, applications due by December 23. Funding will be effective April 1, 2015.


If you qualify based on one of the three criteria listed above, please email a letter of intent in MS Word that includes your name, degree, title and email address and a brief description of your research.  In addition to the LOI email, please include an abstract with the title of your project (NIH form page) of your research, a biosketch and OS page.    If your proposed research is deemed compatible with the goals of the BADERC, instructions for the preparation of a five-page application for a pilot and feasibility research grant award will be forwarded to you. 


Please send letters of intent and abstract page with the title of your project in word via email to



MGH ECOTE Education and Teaching Grant Awards


The MGH Executive Committee on Teaching and Education (ECOTE) is now accepting applications for innovative research studies or pilot projects that investigate innovative, cutting edge approaches to education, especially those focused on one or more of the following themes:


  • Inter-professional education
  • Developing and supporting educators
  • Deliberate practice
  • Competency assessment
  • Providing effective mentorship and feedback
  • Measuring outcomes of teaching/education


Applications materials are available by contacting Andrea Paciello at Applications should describe how the results have the potential to be transformative, scalable across a larger educational platform, and sustainable over time and following the grant funding period.


This award is open to MGH educators from all disciplines.


Application deadline: Monday, December 1



New England Pediatric Device Consortium – RFP for Pressure Ulcer Treatments

The NEPDC is now accepting proposals for novel technologies to reduce, treat, or prevent pediatric pressure ulcers with. Awards target ideas with a clear potential for commercialization, and support efforts that can be leveraged for subsequent funding opportunities (preliminary data, working prototype, business plan). Proposals should include a plan of work. NEPDC is a collaborative consortium providing rapid, targeted assistance to innovators seeking to address the needs of children with diseases or disabilities. Visit or contact us at



Pilot Grant for Neurogenerative Diseases


The Massachusetts Alzheimer’s Disease Research Center (“MADRC”) and the Harvard NeuroDiscovery Center (“HNDC”) are co-funding novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community, including Harvard-affiliated hospitals and institutions. Grants with a dollar value up to $40,000 (direct costs) will be awarded for the duration of one year.  This award cycle anticipates funding between three and six awards.


More information may be found at


Applications due: December 10

Recipients announced: January 15, 2015


Awards start: April 1, 2015


HMS Foundation Funds

The Fall nominatino process for the 2014 HMS Foundation Funds is complete.  Please see the website for further details. 

If you are an MGH investigator, you should not apply directly to HMS for several of the funding opportunities offered through the HMS foundation funds annually. Please see the chart located here to determine where to apply and for information on the process.

If you have any questions, please contact Erin McGivney at 617-643-6471.



2015 Training Program in Nervous System Tumors. National Cancer Institute Paul Calabresi Career Award for Clinical Oncology (K12)


The Massachusetts General Hospital is pleased to offer a National Cancer Institute-sponsored, 2-year research/training fellowship in nervous system tumors. Eligible applicants must be U.S. citizens or permanent U.S. residents, must have completed clinical training in neurology, neurosurgery, medical oncology, pediatric oncology or radiation oncology and must be eligible for HMS appointment at the Fellow or Instructor level. The program consists of 2 years of research experience as well as didactic training in clinical research methodology. Trainees are expected to devote at least 75% effort to research training. Trainees should engage in laboratory-based or clinical translational research on nervous system tumors under the guidance of an experienced mentor.

Applications are due December 1, 2014 for the training period July 1, 2015 - June 30, 2017. Awardees will be notified by December 15, 2014. An application consists of 1) project description (2 pages maximum), 2) curriculum vitae (HMS format) and 3) three letters of recommendation.

Applications should be submitted as a single pdf via email to:
Leah Hesse, Ph.D., K12 Program Administrator,


Limited Submission Funding Opportunities


We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include: 1. Name of the Principal Investigator with appropriate contact information 2. A descriptive title of the potential application 3. Brief description of the project 4. Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities  Please click here for more information and for our internal deadlines.

  • Clinical and Translational Science Award (U54)
  • NIH Director's Early Independence Awards (DP5) – NEW!


If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.


Private Funding Opportunities – Many Pediatric-Oriented Opportunities!


Please contact Corporate & Foundation Relations in the Office of Development at if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

  • AAF Scholar Awards, American Asthma Foundation (AAF)
  • Keith Michael Andrus Memorial Award, Friedreich's Ataxia Research Alliance (FARA)
  • Glenn/AFAR Breakthroughs in Gerontology (BIG) Awards, American Federation for
  • Aging Research (AFAR)
  • NARSAD Independent Investigator, Brain and Behavior Research Foundation
  • New Investigator Awards in Alzheimer's Disease, American Federation for Aging Research (AFAR)
  • Research Grants, A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
  • Julie Martin Mid-Career Award in Aging Research, American Federation for Aging Research

Please click here for further details on these funding opportunities.




Please click here to read the latest news from the Patient-Centered Outcomes Research Institute.


NIH Funding Opportunities


The National Institutes of Health is challenging science innovators to compete for prizes totaling up to $500,000, by developing new ways to track the health status of a single cell in complex tissue over time. The NIH Follow that Cell Challenge seeks tools that would, for example, monitor a cell in the process of becoming cancerous, detect changes due to a disease-causing virus, or track how a cell responds to treatment. For more information, please click here.


For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link:


What will we discover next?

Learn how researchers at MassGeneral Hospital for Children are finding new treatments that advance pediatric care.